Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pet-ct”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07448623
What this trial is testing

A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT Imaging in People With ATTR Amyloidosis.

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Novo Nordisk A/S 14
Not applicableTemporarily pausedNCT07242690
What this trial is testing

PET-CT Imaging With PCD-CT

Who this might be right for
Head and Neck Cancer (H&N)
Medical University of South Carolina 20
Very early researchEnded earlyNCT04221061
What this trial is testing

18F-FluorThanatrace (PET/CT) in Glioblastoma

Who this might be right for
Glioblastoma
University of Pennsylvania 3
Not applicableNot Yet RecruitingNCT07022080
What this trial is testing

Evaluating the Effectiveness of 68Ga-grazytracer PET/CT in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases (IBD)
Xijing Hospital 69
Not applicableActive Not RecruitingNCT02899312
What this trial is testing

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstate Cancer
British Columbia Cancer Agency 2,244
Large-scale testing (Phase 3)Looking for participantsNCT06282588
What this trial is testing

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

Who this might be right for
Prostate Cancer
Cancer Research Antwerp 493
Post-approval studies (Phase 4)UnknownNCT02621541
What this trial is testing

Nonfunctional Pancreatic NET and PET Imaging

Who this might be right for
Diagnosis
Turku University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00316901
What this trial is testing

Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial

Who this might be right for
Kidney CancerMelanoma (Skin)
National Institutes of Health Clinical Center (CC) 70
Not applicableUnknownNCT05819905
What this trial is testing

Radiomics for prEdiction of lunG cAncer biologY

Who this might be right for
Non Small Cell Lung CancerPET/CTPD-L1+1 more
Poitiers University Hospital 600
Large-scale testing (Phase 3)Ended earlyNCT00522639
What this trial is testing

Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation

Who this might be right for
Lung CancerSCLCNSCLC
Maastricht Radiation Oncology 120
Not applicableUnknownNCT03572595
What this trial is testing

F-18 FDG- PETCT in Staging and Recurrent Colorectal Cancer

Who this might be right for
Colo-rectal CancerRecurrence
Assiut University 45
Very early researchNot Yet RecruitingNCT07790939
What this trial is testing

89Zr-DFO-Mirvetuximab PET/CT Imaging for Companion Diagnosis and Response Evaluation in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian Cancer
Peking University Cancer Hospital & Institute 20
Large-scale testing (Phase 3)UnknownNCT03344822
What this trial is testing

Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Central Hospital, Nancy, France 33
Not applicableLooking for participantsNCT06358222
What this trial is testing

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

Who this might be right for
CarcinomaNon-small Cell Lung Cancer
Shanghai Chest Hospital 200
Not applicableStudy completedNCT02144311
What this trial is testing

Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 26
Not applicableStudy completedNCT02378337
What this trial is testing

Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality

Who this might be right for
Malignant Neoplasm of BreastHodgkin DiseaseNon-Hodgkin Lymphoma, Follicular (Nodular)+5 more
Hospital Sao Rafael 335
Testing effectiveness (Phase 2)Ended earlyNCT04631601
What this trial is testing

Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 55
Early research (Phase 1)Active Not RecruitingNCT02284919
What this trial is testing

[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasm
University of Pennsylvania 30
Not applicableLooking for participantsNCT05541367
What this trial is testing

Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

Who this might be right for
Breast CancerTNBC - Triple-Negative Breast CancerEstrogen-receptor-negative Breast Cancer
Tongji Hospital 80
Not applicableStudy completedNCT05270967
What this trial is testing

FDG (Fluorodeoxyglucose) Findings After COVID-19 Vaccination

Who this might be right for
Vaccine ReactionOncology
Kocaeli University 129
Next Page